Display Settings:

Format

Send to:

Choose Destination
Ann Intern Med. 2003 Dec 16;139(12):959-65.

Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer.

Author information

  • 1Indiana University School of Medicine, Indiana University, Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana, USA.

Abstract

BACKGROUND:

Colonoscopic screening for colorectal cancer has been suggested because sigmoidoscopy misses nearly half of persons with advanced proximal neoplasia.

OBJECTIVE:

To create a clinical index to stratify risk for advanced proximal neoplasia and to identify a subgroup with very low risk in which screening sigmoidoscopy alone might suffice.

DESIGN:

Cross-sectional study.

SETTING:

A company-based program of screening colonoscopy for colorectal cancer.

PATIENTS:

Consecutive persons 50 years of age or older undergoing first-time screening colonoscopy between September 1995 and June 2001.

MEASUREMENTS:

A clinical index with 3 variables was created from information on the first 1994 persons. Points were assigned to categories of age, sex, and distal findings. Risk for advanced proximal neoplasia (defined as an adenoma 1 cm or larger or one with villous histology, severe dysplasia, or cancer) was measured for each score. The index was tested on the next 1031 persons from the same screening program.

RESULTS:

Of 1994 persons, 67 (3.4%) had advanced proximal neoplasia. A low-risk subgroup comprising 37% of the cohort had scores of 0 or 1 and a risk of 0.68% (95% CI, 0.22% to 1.57%). Among the validation group of 1031 persons, risk for advanced proximal neoplasia in the low-risk subgroup (comprising 47% of the cohort) was 0.4% (upper confidence limit of 1.49%). Application of this index detected 92% of persons with advanced proximal neoplasms and, if applied following screening sigmoidoscopy, could reduce the need for colonoscopy by 40%. The marginal benefit of colonoscopy among low-risk persons was small: To detect 7 additional persons with advanced proximal neoplasia, 1217 additional colonoscopies would be required.

CONCLUSIONS:

This clinical index stratifies the risk for advanced proximal neoplasia and identifies a subgroup at very low risk. If it is validated in other cohorts or groups, the index could be used to tailor endoscopic screening for colorectal cancer.

Comment in

PMID:
14678915
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk